PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Evolution of treatment for intracranial aneurysm • Evolution of treatment for intracranial aneurysm: From clipping to flow diverters PART 04: Market research methodology • Research methodology • Economic indicators PART 05: Introduction • Key market highlights • Flow diversion devices • Regulatory environment PART 06: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 07: Ongoing clinical trials and approved indications for flow diverters PART 08: Evolution of endovascular aneurysm treatment • Past • Present PART 09: Geographical segmentation • Flow diversion aneurysm treatment market in Americas • Market size and forecast • Flow diversion aneurysm treatment market in EMEA • Market size and forecast • Flow diversion aneurysm treatment market in APAC • Market size and forecast PART 10: Buying criteria PART 11: Market drivers • Increase in instances of brain aneurysm caused by cerebral disorders • Growing adoption by surgeons • Increase in demand for minimally invasive endovascular surgeries • Rise in awareness PART 12: Impact of drivers PART 13: Market challenges • Complications associated with cerebrovascular/neurovascular procedures • Threat of alternative treatments • Inadequate clinical evidence • Manufacturing hurdles and delay in product launches due to stringent regulatory environment PART 14: Impact of drivers and challenges PART 15: Market trends • Product approvals and tentative investigational product launches • Ongoing clinical trials • Huge market potential for new entrants • Rise in demand for intracranial stenting procedures PART 16: Vendor landscape • Competitive scenario • Product matrix PART 17: Key vendor analysis • Balt Extrusion • Medtronic • MicroVention • Stryker • Other prominent vendors PART 18: Appendix • List of abbreviations PART 19: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Evolution of treatments for intracranial aneurysm Exhibit 03: Global neurointerventional devices market 2015 Exhibit 04: Top vendors in global neurosurgery devices market 2015 Exhibit 05: Individuals showing symptoms indicative of unruptured aneurysm 2014 Exhibit 06: Comparison of different types of treatments for intracranial aneurysm Exhibit 07: FDA classification on medical device by type of class Exhibit 08: Global flow diversions aneurysm treatment market analysis: Developed and emerging markets Exhibit 09: Global flow diversion aneurysm treatment market 2015-2020 ($ millions) Exhibit 10: Opportunity analysis of global flow diversion aneurysm treatment market Exhibit 11: Five forces analysis Exhibit 12: Major clinical trials for endovascular aneurysm and flow diversion treatment Exhibit 13: Approved indications for flow diverters in US and Europe Exhibit 14: Volume units across all neurovascular coiling procedures 2014 Exhibit 15: Vendors and products available Exhibit 16: Number of flow diversion procedures performed in 2013 Exhibit 17: Number of flow diversion procedures performed in 2014 Exhibit 18: Global flow diversion aneurysm treatment market: Geographical presence Exhibit 19: Global flow diversion aneurysm treatment market: Geography lifecycle analysis 2015 Exhibit 20: Global flow diversion aneurysm treatment market by geography 2015 and 2020 Exhibit 21: Global flow diversion aneurysm treatment market by geography 2015 Exhibit 22: Flow diversion aneurysm treatment market in Americas 2015-2020 ($ millions) Exhibit 23: Flow diversion aneurysm treatment market in EMEA 2015-2020 ($ millions) Exhibit 24: Flow diversion aneurysm treatment market in APAC 2015-2020 ($ millions) Exhibit 25: Flow diversion aneurysm treatment market by geography 2015-2020 ($ millions) Exhibit 26: Flow diversion aneurysm treatment market by geography 2015-2020 Exhibit 27: Key buying criteria for flow diversion aneurysm treatment Exhibit 28: Impact of drivers Exhibit 29: Reported cases of rupture at later stage in large aneurysm (17-35 mm) Exhibit 30: Impact of drivers and challenges Exhibit 31: Vendors and products available in market Exhibit 32: Product matrix Exhibit 33: Balt Extrusion: Distributors Exhibit 34: Balt Extrusion: Metric analysis Exhibit 35: Medtronic: Product segmentation Exhibit 36: Medtronic: Restorative therapies group by revenue 2013-2015 ($ billions) Exhibit 37: Medtronic: Metric analysis Exhibit 38: MicroVention: Distributors Exhibit 39: MicroVention: Metric analysis Exhibit 40: Stryker: Product segmentation Exhibit 41: Stryker: Neurotechnology and spine segment by revenue 2013-2015 ($ billions) Exhibit 42: Stryker: Metric analysis

Balt Extrusion, Medtronic, MicroVention, Stryker, Acandis, InspireMD, Phenox.